Home application
 

Keywords :   


Tag: application

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review

2015-08-18 14:00:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Merck Provides Additional Update: FDA Extends Action Date for Additional sBLA in Ipilimumab-Refractory Advanced Melanoma KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy. Merck is seeking approval for KEYTRUDA, at the currently approved dose of 2 mg/kg every three weeks, for the first-line treatment of unresectable or metastatic melanoma patients. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orInvestors:Justin Holko, 908-740-1879An Phan, 908-255-6325 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: advanced review application license

 

Cybera And Verizon Simplify Business Application Delivery

2015-08-18 07:22:43| wirelessdesignonline News Articles

Franklin-based technology company, Cybera, creates solutions that help distributed enterprises connect the applications they need. With Cybera, enterprises provide their customers with a fast and convenient experience, while also keeping their networks secure.

Tags: business application delivery verizon

 
 

3.103.060 Application Approval.

2015-08-14 18:11:10| PortlandOnline

Tags: application approval

 

3.103.050 Application Review.

2015-08-14 18:10:40| PortlandOnline

Tags: review application

 

Task Force Interest Application

2015-08-13 21:01:04| PortlandOnline

Word Document, 55kbCategory: Other Materials

Tags: interest application force task

 

Sites : [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] next »